Back to companies
PORTFOLIO
Noscendo
Noscendo offers a completely new way of identifying pathogens causing diseases in patients. Through a paradigm shift based on proprietary algorithms and software harnessing next-generation sequencing data, Noscendo identifies pathogens from patient samples. This supports physicians to make the right decisions in difficult situations and in a relevant time frame.
Milestones
Founded: 2017 Invested: 2020
Leadership Team
Andreas Käpplein
HQ
Duisburg, Germany
Earlybird Deal Team

OUR PORTFOLIO
SIMILAR COMPANIES
Meet the companies we’ve backed on their way to creating groundbreaking change.
WE INVEST BECAUSE
WE BELIEVE
Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.






